Inheritance
Sickle hemoglobin (Hb S) is inherited as autosomal recessive from both parents or Hb S from one parent and a gene for an abnormal hemoglobin or beta-thalassemia from the other parent.
Characteristics
Acute and chronic tissue injury can occur when blood flow through the vessels is obstructed by abnormally shaped red cells. Complications include painful episodes involving soft tissues and bones, acute chest syndrome, priapism, cerebral vascular accidents, and both splenic and renal dysfunction. Common causes of mortality among children with sickle cell disease include bacterial infections, splenic sequestration crisis, and acute chest syndrome.
Variant Forms
Types of sickle cell disease include sickle cell anemia (SS), hemoglobin SC disease, sickle beta thalassemia, and SE disease. Other hemoglobin diseases include hemoglobin CC and EE diseases.
Newborn Screening Methodology
The laboratory method used is Isoelectric Focusing (IEF) and High Performance Liquid Chromatography (HPLC).
Confirmation
Health care providers should seek consultation from a Pediatric Hematology Consultant, (319) 356-1400. If the newborn screen result is abnormal, a second specimen should be obtained and sent to the INMSP lab. DNA analysis of the infant's beta globin gene complex also may be used to establish a definitive diagnosis.
Treatment and Outcome
Any sign of illness in an infant with sickle cell disease is a potential medical emergency. Infants with sickle cell disease should receive standard well baby care, including pneumococcal vaccination. Infants with documented or suspected sickle cell anemia or Hb S/ Beta thalassemia should be started on twice-daily oral prophylactic penicillin as soon as possible, but no later than two months of age. Infants with suspected sickle cell disease should be maintained on prophylactic penicillin until the definitive diagnosis is established. Parents of infants with sickle cell disease should be instructed in all aspects of routine childcare and should be able to determine accurately the infant's temperature. Parents must understand the importance of prompt assessment of the infant by a physician knowledgeable about sickle cell disease when there is fever, pallor, unexplained irritability, diarrhea, vomiting, or other signs of illness. Some infants will be identified as a hemoglobin trait carrier. Practitioners are strongly encouraged to have blood specimens drawn on each parent to determine their carrier status. Genetic counseling should be offered. The Regional Genetics Consultation Service (1-800-260-2065) provides genetic counseling and evaluation at outreach clinics statewide.
Screening Practice Considerations
• The newborn screen should detect most abnormal hemoglobin subtypes. However, it is not always possible to identify beta thalassemia with this test.
• The newborn screen for hemoglobinopathies is not affected by age at collection.
• Blood transfusions may result in false negative results. Always obtain a newborn screening specimen prior to a transfusion.
• The primary purpose of hemoglobinopathy screening is the identification of infants with sickle cell diseases for whom early intervention has been shown to markedly reduce morbidity and mortality.
• The screening test is not diagnostic and all abnormal results should be confirmed.
• Only filter paper specimens are tested in the INMSP. All initial abnormal hemoglobin results should be immediately followed up with a second filter paper newborn screening specimen.
• Solubility testing (sickle prep or sickle dex) should never be used. It is an inadequate method of screening.
• A properly performed hemoglobin electrophoresis should be used to verify the presence/absence of an abnormal hemoglobin.
• Hemoglobinopathies are complex disorders, and practitioners will be sent consult follow-up resources for more information concerning abnormal screening results and appropriate follow-up and treatment.
Explanation of Report Results/Comments Specific to Hemoglobinopathies
Normal expected patterns: FA Fetal hemoglobin is greater than adult hemoglobin. Normal pattern in newborn < 3 weeks of age. AF Adult hemoglobin is greater than fetal hemoglobin. Normal pattern in newborn >3 weeks of age, provided NO TRANSFUSION had taken place within the last eight weeks and anemia is not suspected.
Transfused/unknown transfusion status:
Blood transfusions will interfere with the interpretation of screening results. If patient was transfused, resubmit another filter paper specimen eight weeks after the last transfusion.
A>F Adult hemoglobin is greater than or equal to fetal hemoglobin. IF TRANSFUSED, send other FILTER PAPER specimen collected at least 8 weeks after the last transfusion.
F only:
Individuals with only fetal (F) hemoglobin without detectable normal hemoglobin A (adult) need immediate follow-up testing to determine if this is caused by prematurity or the absence of the hemoglobin A (adult) gene.
FF Hemoglobin F only may indicate a delayed appearance of hemoglobin A (prematurity), hereditary persistence of fetal hemoglobin, or betathalassemia major.
Disease:
Individuals with disease have two abnormal hemoglobin genes (i.e., SS, SC, CC, etc.) without the normal hemoglobin gene A (adult 
